Business Description
Biolase Inc
NAICS : 339114
SIC : 5047
ISIN : US0909112072
Description
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | -0.19 | |||||
| Debt-to-Equity | -3.58 | |||||
| Debt-to-EBITDA | -1.71 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -17.29 | |||||
| Beneish M-Score | -3.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -65.7 | |||||
| 3-Year EBITDA Growth Rate | 72.4 | |||||
| 3-Year EPS without NRI Growth Rate | 72.5 | |||||
| 3-Year FCF Growth Rate | 71.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.1 | |||||
| 9-Day RSI | 45.98 | |||||
| 14-Day RSI | 46.6 | |||||
| 6-1 Month Momentum % | -90.98 | |||||
| 12-1 Month Momentum % | -99.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.63 | |||||
| Quick Ratio | 0.31 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 138.63 | |||||
| Days Sales Outstanding | 37.95 | |||||
| Days Payable | 64.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -343.8 | |||||
| Shareholder Yield % | -1294.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.44 | |||||
| Operating Margin % | -29.37 | |||||
| Net Margin % | -34.84 | |||||
| FCF Margin % | -29.57 | |||||
| ROA % | -48.28 | |||||
| ROIC % | -60.29 | |||||
| ROC (Joel Greenblatt) % | -165.23 | |||||
| ROCE % | -157.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.14 | |||||
| EV-to-EBITDA | -1.42 | |||||
| EV-to-Forward-EBITDA | -4.31 | |||||
| EV-to-Revenue | 0.34 | |||||
| EV-to-Forward-Revenue | 0.32 | |||||
| EV-to-FCF | -1.14 | |||||
| Earnings Yield (Greenblatt) % | -87.72 | |||||
| FCF Yield % | -4949.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOLQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biolase Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 46.026 | ||
| EPS (TTM) ($) | -2.039 | ||
| Beta | 0.98 | ||
| Volatility % | 148 | ||
| 14-Day RSI | 46.6 | ||
| 14-Day ATR ($) | 0.003417 | ||
| 20-Day SMA ($) | 0.008313 | ||
| 12-1 Month Momentum % | -99.53 | ||
| 52-Week Range ($) | 0.004 - 1.27 | ||
| Shares Outstanding (Mil) | 36.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biolase Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biolase Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biolase Inc Frequently Asked Questions
What is Biolase Inc(BIOLQ)'s stock price today?
The current price of BIOLQ is $0.01. The 52 week high of BIOLQ is $1.27 and 52 week low is $0.00.
When is next earnings date of Biolase Inc(BIOLQ)?
The next earnings date of Biolase Inc(BIOLQ) is 2025-03-21 Est..
Does Biolase Inc(BIOLQ) pay dividends? If so, how much?
Biolase Inc(BIOLQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers